- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Multiple Dose in New Zealand
Total 2248 results
-
Johns Hopkins UniversityPatient-Centered Outcomes Research Institute; National Multiple Sclerosis SocietyRecruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
Rochester General HospitalActive, not recruitingNasopharyngeal Colonization and Acute Otitis MediaUnited States
-
University of California, Los AngelesMichael E. DeBakey VA Medical Center; Atlanta VA Medical Center; VA Greater Los... and other collaboratorsRecruitingCOVID-19 | Frailty Syndrome | Long COVID | Post Acute Sequelae of COVID-19 | Organ Dysfunction Syndrome, MultipleUnited States
-
OncotherapeuticsCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
State University of New York - Upstate Medical...Terminated
-
University at BuffaloCompletedMultiple SclerosisUnited States
-
Memorial Sloan Kettering Cancer CenterCelgene; Onyx/AmgenActive, not recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Not yet recruitingMultiple MyelomaAustralia
-
Yale UniversityGlaxoSmithKlineRecruitingMultiple MyelomaUnited States
-
Hackensack Meridian HealthAmgenRecruitingMultiple MyelomaUnited States
-
Hackensack Meridian HealthActive, not recruitingMultiple MyelomaUnited States
-
Hackensack Meridian HealthTerminatedMultiple MyelomaUnited States
-
Yale UniversityCompleted
-
Yale UniversityCelgene CorporationCompletedMultiple MyelomaUnited States
-
University of RochesterTerminatedMultiple MyelomaUnited States
-
Manish Mehta, MDCenter for Vascular Awareness, Albany, New YorkTerminatedMultiple SclerosisUnited States
-
BiogenCompletedRelapsing Forms of Multiple SclerosisUnited States
-
ENT and Allergy Associates, LLPIntersect ENTCompleted
-
Optinose US Inc.CompletedChronic RhinosinusitisUnited States, Australia, Poland, New Zealand, Spain, Georgia, United Kingdom, Bulgaria, Czechia, Romania
-
BiogenCompletedMultiple Sclerosis, Relapsing-RemittingUnited States, Spain, Canada, Australia, Germany, Italy, United Kingdom, Belgium, Netherlands, France, Israel
-
Genzyme, a Sanofi CompanyBayerCompletedMultiple Sclerosis, Relapsing-RemittingAustralia, France, United States, Germany, Canada, United Kingdom, Russian Federation, Argentina, Brazil, Croatia, Poland, Serbia, Sweden, Ukraine, Czech Republic, Mexico
-
Kessler FoundationEnrolling by invitationMultiple Sclerosis | Emotional DisturbancesUnited States
-
Stony Brook UniversityCompletedMultiple SclerosisUnited States
-
Oncopeptides ABApproved for marketingRelapsed and/or Refractory Multiple MyelomaUnited States
-
BiogenCompletedRelapsing Forms of Multiple SclerosisUnited States
-
NYU Langone HealthCompletedDysphagiaUnited States
-
University of RochesterNational Cancer Institute (NCI)RecruitingMyelomaUnited States
-
Multiple Sclerosis Center of Northeastern New YorkMerz North America, Inc.CompletedMultiple Sclerosis | Muscle SpasticityUnited States
-
Kessler FoundationKessler Institute for RehabilitationRecruitingMultiple Sclerosis | Cognitive Impairment | Gait Disorders, Neurologic | Motility DisorderUnited States
-
Click Therapeutics, Inc.CompletedMultiple Sclerosis | Cancer | Mild Cognitive ImpairmentUnited States
-
Weill Medical College of Cornell UniversityCelgene CorporationTerminatedMultiple MyelomaUnited States
-
NYU Langone HealthCephalonTerminated
-
University Hospital MuensterCompleted
-
Providence Health & ServicesMultiple Sclerosis Center of Northeastern New YorkCompleted
-
University of RochesterEnrolling by invitation
-
NYU Langone HealthTerminated
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedHead and Neck CancerUnited States
-
NovartisCompletedMultiple SclerosisUnited States, Korea, Republic of, Portugal, Canada, Hungary, Spain, Germany, United Kingdom, Australia, Argentina, Austria, Belgium, Brazil, Egypt, France, Greece, Italy, Switzerland
-
University of Texas Southwestern Medical CenterAspreva PharmaceuticalsCompletedMultiple SclerosisUnited States
-
Meda PharmaceuticalsCompletedChronic Allergic Rhinitis | Nonallergic RhinitisUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruiting
-
National Center for Research Resources (NCRR)Completed
-
ChimerixActive, not recruiting
-
Weill Medical College of Cornell UniversityMillennium Pharmaceuticals, Inc.Completed
-
Genzyme, a Sanofi CompanyAnorMEDTerminatedMultiple MyelomaUnited States
-
CephalonTerminated
-
National Institute of Allergy and Infectious Diseases...Genentech, Inc.; Rho Federal Systems Division, Inc.; Autoimmunity Centers of...RecruitingMultiple SclerosisUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedHead and Neck Cancer | Nasopharynx Cancer | Oropharynx Cancer | Oral Cavity Cancer | Larynx Cancer | Paranasal Sinus Cancer | Hypopharynx CancerUnited States
-
Merck Sharp & Dohme LLCActive, not recruitingPIK3CA-Related Overgrowth Spectrum (PROS)/Proteus Syndrome (PS)United States, Australia, Brazil, Italy, United Kingdom
-
CochlearNYU Langone HealthTerminated